Bone Morphogenetic Protein Market
According to Intent Market Research, the Bone Morphogenetic Protein Market is expected to grow from USD 472.2 million in 2023 at a CAGR of 6.6% to touch USD 738.7 million by 2030. The Bone Morphogenetic Protein Market is dominated by key players such as, Cellumed Co., Ltd., Medtronic plc, Prospec-Tany Technogene Ltd., Proteintech Group, Inc., and Bio-Techne.